Workshops to bring together industry and NHS researchers

pharmafile | March 14, 2008 | News story | |  ABPI 

The pharma industry and interested NHS researchers will come together in a new initiative aimed at increasing and accelerating clinical research collaborations.

The ABPI and the Department of Health have organised the series of regional workshops, and say they could help clinical trials in the NHS be set up more effectively and rapidly.

ABPI medical director Dr Richard Tiner said: "The UK-based pharmaceutical industry has much to offer the NHS in terms of skills and knowledge. The ABPI and its member companies are committed to sharing these resources for the benefit of patients.

Advertisement

"The workshops will allow the industry and the NHS to work together effectively on future projects and share best practice.

"In the UK, the pharmaceutical industry invests £10 million every day researching and developing innovative, new medicines. The regional workshops will allow an even greater focus on the development of new medicines by improving the clinical trials process."

The workshops will provide NHS researchers and research managers, pharmaceutical and biopharmaceutical companies, CROs and medical schools with the chance to discuss the Model Clinical Trial Agreements and other tools developed to allow faster set-up and starts for UK clinical trials.

The meeting will also provide a forum for both sides to discuss the issues faced by companies sponsoring trials in the UK.

The first event was held on 13 March in Southampton, and eight more are scheduled at locations throughout the UK.

The regional workshop dates

Southampton – 13 March

Manchester – 17 March

Cambridge – 18 March

Birmingham – 9 March

London – 14 April

Newcastle – 6 May

Edinburgh – 7 May

Cardiff – 14 May

Related Content

pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!

brexit-hintergrund_web

UK life sciences industry does not want no-deal Brexit, says ABPI Chief

Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …

mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike …

The Gateway to Local Adoption Series

Latest content